DOI: 10.1128/mBio.00161-15
Article Information
PubMed
Published By
History
- Received February 5, 2015
- Accepted February 6, 2015
- Published online March 17, 2015.
Copyright & Usage
Copyright © 2015 Burstein et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-ShareAlike 3.0 Unported license, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
Editors and / or Reviewers
- Stephen Carlyle Winans, Editor, Cornell University
Author Information
- David Bursteina*,
- Shirley Satanowerb,c,
- Michal Simovitchb,c,
- Yana Belnikb,c,
- Meital Zehavib,c,
- Gal Yerushalmib,c,
- Shay Ben-Aroyab,
- Tal Pupkoa,
- Ehud Baninb,c
- aDepartment of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv, Israel
- bThe Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel
- cThe Institute for Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan, Israel
- Address correspondence to Tal Pupko, talp{at}tau.ac.il, or Ehud Banin, ehud.banin{at}biu.ac.il.
↵* Present address: David Burstein, Department of Earth and Planetary Science, UC Berkeley, Berkeley, California, USA.
D.B., S.S., and M.S. contributed equally to this work.
Citation Burstein D, Satanower S, Simovitch M, Belnik Y, Zehavi M, Yerushalmi G, Ben-Aroya S, Pupko T, Banin E. 2015. Novel type III effectors in Pseudomonas aeruginosa. mBio 6(2):e00161-15. doi:10.1128/mBio.00161-15.
